1 Min Read
Nov 7 (Reuters) - Collegium Pharmaceutical Inc
* Collegium receives FDA approval for sNDA for Xtampza® ER Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.